跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Recombinant botulinum toxin type A
首页
药物
Recombinant botulinum toxin type A
Recombinant botulinum toxin type A
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Soluble recombinant botulinum toxin proteins
US 2005238665 A1
申请人: ALLERGAN INC ALLERGAN BOTOX LT
优先权: 2002
US
7 件公开
RECOMBINANT BOTULINUM TOXIN TYPE A LIGHT CHAIN, RECOMBINANT BOTULINUM TOXIN, AND COMPOSITION, USE, AND METHOD THEREOF
EP 4365190 A4
申请人: MEDYTOX INC
优先权: 2021
CN
EP
US
WO
4 件公开
EP 4365191 A4
申请人: MEDYTOX INC
优先权: 2021
CN
EP
US
WO
4 件公开
RECOMBINANT BOTULINUM TOXIN LIGHT CHAIN PROTEIN COMPOSITION HAVING ENHANCED STABILITY
WO 2022071671 A1
申请人: LG HOUSEHOLD & HEALTH CARE LTD
优先权: 2020
CN
WO
2 件公开
RECOMBINANT BOTULINUM TOXIN AND PREPARATION METHOD THEREFOR
WO 2026148729 A1
申请人: LEPU JIANTANG PHARMACEUTICAL CHONGQING CO LTD
优先权: 2025
CN
WO
2 件公开
Methods of treating animals with botulinum toxin pharmaceutical compositions
US 2002064536 A1
申请人: ALLERGAN SALES INC
优先权: 2002
US
Novel DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain for production of therapeutics
US 2005169942 A1
申请人: ALLERGAN INC
优先权: 2004
US
Method for preparing anti-A type botulinus toxin immunoglobulin antibody
CN 101497909 B
申请人: INST BIOENGINEERING AMMS
优先权: 2009
CN
PREPARATION METHOD FOR BOTULINUM TOXIN TYPE A AND USE OF SAME
WO 2024250799 A1
申请人: SHENZHEN REJUVO BIOTECHNOLOGY CO LTD
优先权: 2023
WO
Preparation and application of botulinum toxin receptor binding domain probe molecule
CN 119574853 A
申请人: UNIV LANZHOU
优先权: 2023
CN
RECOMBINANT POLYPEPTIDE, COMPOSITION COMPRISING SAME, USES THEREOF, AND METHODS THEREFOR
WO 2025221026 A1
申请人: MEDYTOX INC
优先权: 2024
WO
第 1 / 2 页
上一页
下一页
药物
反馈